| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director
2 companies
Ho Carole is a Chief Medical Officer at Denali Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 2,857 | $24.15 | $68,996.55 | -1.5% | -16.7% | -7.6% | |
| Feb 15, 2023 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 1,476 | $29.40 | $43,394.40 | -0.8% | -3.2% | -39.3% | |
| Feb 13, 2023 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 3,366 | $30.03 | $101,071.20 | -0.9% | +6.1% | -43.5% | |
| Feb 8, 2023 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 1,521 | $30.88 | $46,968.48 | -0.8% | -10.4% | -43.6% | |
| Jan 9, 2023 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 1,459 | $28.48 | $41,552.32 | -0.8% | -13.5% | -29.1% | |
| Jan 6, 2023 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 4,087 | $28.52 | $116,568.01 | -1.1% | -16.0% | -33.1% | |
| Jan 4, 2023 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 2,913 | $28.69 | $83,573.97 | -1.6% | -18.1% | -29.9% | |
| Aug 23, 2022 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 2,424 | $31.98 | $77,519.52 | -1.4% | -8.3% | -28.9% | |
| Aug 19, 2022 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 2,576 | $33.22 | $85,574.72 | -1.5% | -12.6% | -31.9% | |
| Feb 11, 2022 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 2,918 | $34.71 | $101,283.78 | -1.7% | -37.4% | -16.4% |